Purchases and Sales Made in Q4 2023 in Acumen Pharmaceuticals, Inc. (ABOS)
This table provides information about the institutional ownership of Acumen Pharmaceuticals, Inc. (ABOS) during Q4 2023. The information is specifically focused on institutions that hold shares of Acumen Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 12, 2024
Q4 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
200+ 100.0% |
$372 - $896
|
400
$740
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
SELL
|
- |
-92- 92.0% |
$171 - $412
|
8
$14.8
|
|
|
Jan 18, 2024
Q4 2023
|
Cutler Group LP
|
SELL
|
- |
-1.3K- 52.0% |
$2.42K - $5.82K
|
1.2K
$2.22K
|
|
|
Jan 30, 2024
Q4 2023
|
Zurcher Kantonalbank (Zurich Cantonalbank)
Zurich, V8 |
SELL
|
- |
-2.98K- 87.83% |
$5.54K - $13.4K
|
413
$764
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-17K- 0.92% |
$31.6K - $76.2K
|
1.84M
$3.4M
|
|
|
Feb 07, 2024
Q4 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-19.8K- 26.2% |
$36.8K - $88.8K
|
55.8K
$103K
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-64.7K- 73.66% |
$120K - $290K
|
23.1K
$42.8K
|
|
|
Feb 14, 2024
Q4 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-83.6K- 12.95% |
$155K - $374K
|
562K
$1.04M
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-335K- 57.48% |
$624K - $1.5M
|
248K
$459K
|
|
|
Feb 14, 2024
Q4 2023
|
Rock Springs Capital Management LP
Baltimore, MD |
SELL
|
- |
-513K- 18.22% |
$953K - $2.3M
|
2.3M
$4.26M
|